In a critical global public health development, a candidate vaccine for tuberculosis (TB) has been created using a gene-editing approach. TB remains the leading cause of death by infectious disease globally, with South...
In a study from Boston University’s National Emerging Infectious Diseases Laboratories (NEIDL), researchers have generated a map of the cellular circuitry of Mycobacterium tuberculosis, the causative agent of...
A handheld diagnostic device that Massachusetts General Hospital (MGH) investigators first developed to diagnose cancer has been adapted to rapidly diagnose tuberculosis (TB) and other important infectious bacteria. Two...
Of the 9.4 million new tuberculosis (TB) cases diagnosed each year, approximately 5% are multidrug resistant (MDR).🔒 Premium Content - For FreeUnlock this content by becoming a Global Health Press subscriber. Join for...